-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Carbidopa monohydrate is a pharmaceutical drug that is primarily used to treat Parkinson's disease.
It is also used to treat certain other movement disorders, such as dystonia and Huntington's disease.
In the chemical industry, carbidopa monohydrate is used as an intermediate in the production of other chemicals and pharmaceuticals.
To produce carbidopa monohydrate, the starting material is L-dopa, which is an amino acid that is found naturally in certain plants and animals.
L-dopa is converted into carbidopa monohydrate through a series of chemical reactions, which involve the use of various chemical reagents and catalysts.
The first step in the synthesis of carbidopa monohydrate is the conversion of L-dopa into a pre-cursor compound called 3-hydroxy-L-tyrosine (3-HTP).
This reaction is typically carried out using hydrogen peroxide and a catalyst, such as sodium hydroxide or potassium hydroxide.
Next, the 3-HTP is treated with a series of chemical reagents, including acetic anhydride, sodium acetate, hydrogen chloride, and sodium hydroxide, to produce carbidopa.
The carbidopa is then treated with a solution of water and hydrochloric acid to produce carbidopa monohydrate.
The final step in the synthesis of carbidopa monohydrate is the purification of the product.
This is typically done using a series of chromatography techniques, such as high-performance liquid chromatography (HPLC) or column chromatography.
These techniques are used to separate the carbidopa monohydrate from any impurities that may be present in the reaction mixture.
Once the carbidopa monohydrate has been purified, it is typically dried and ground into a fine powder.
This powder can then be used as an intermediate in the production of other chemicals and pharmaceuticals, or it can be used directly in the treatment of Parkinson's disease and other movement disorders.
Carbidopa monohydrate is a commonly used intermediate in the production of other chemicals and pharmaceuticals, and it is also widely used in the treatment of Parkinson's disease and other movement disorders.
The synthesis of carbidopa monohydrate involves a series of chemical reactions, which are typically carried out using various chemical reagents and catalysts.
The purification of the carbidopa monohydrate is typically done using chromatography techniques, such as HPLC or column chromatography.